PAG is one of the Asia-focused investment managers which delivers value to investors and helps them reach their full potential.
Business Model:
Revenue: $32M
Employees: 201-500
Address: 1 Queen's Road East
City: Hong Kong
State: other
Zip:
Country: HK
PAG is now one of the region’s largest Asia-focused investment managers with funds under management across Private Equity, Real Estate, and Absolute Return strategies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2022 | iQiyi | Post-IPO Debt | 500M |
1/2022 | NMS Group | Private Equity Round | 0 |
3/2013 | COSMIC COLOR | Seed Round | 18.2k |
9/2019 | BioRay Pharmaceutical | Private Equity Round | 540M |
5/2022 | Prenetics | Post-IPO Equity | 0 |
1/2021 | Mobvista | Debt Financing | - |
12/2013 | Universal Studios Japan | Private Equity Round | 250M |
12/2020 | Naixuecha | Series C | 100M |
3/2012 | Bicon Pharmaceutical | Post-IPO Equity | 250M |
10/2016 | Paradise Group | Private Equity Round | - |
4/2018 | Shengxinbao | Series B | 31.7M |
8/2021 | Inceptio Technology | Series B | 0 |
11/2018 | Alphamab Oncology | Series A | 0 |
11/2020 | Regional Express Holdings | Post-IPO Debt | 0 |
7/2022 | Regional Express Holdings | Post-IPO Equity | 0 |
3/2017 | Chezhibao | Series C | 100M |
2/2020 | Yi Zizhu | Venture Round | 14.3M |
1/2019 | Carzone | Series C | 380M |
1/2006 | Haohaizi | Series B | 120M |
5/2019 | Alphamab Oncology | Series B | 60M |
3/2022 | Arabica | Seed Round | - |
7/2017 | Dashu Finance | Series C | 118M |
12/2015 | Dashu Finance | Series B | 77M |
8/2022 | Elan Group | Private Equity Round | 53.1M |
3/2017 | Dadao Financial | Series B | 29M |
12/2015 | Dadao Financial | Series A | - |
12/2017 | U Gro Capital | Private Equity Round | 0 |
12/2022 | Elan Group | Private Equity Round | 57.6M |
3/2020 | Akouos | Series B | 105M |
6/2018 | Chezhibao | Series D | 0 |
3/2017 | Yingde Gases | Private Equity Round | - |
2/2017 | Food Union Group | Private Equity Round | 225M |
7/2022 | Regional Express Holdings | Post-IPO Equity | 0 |
5/2022 | Prenetics | Post-IPO Equity | 0 |
1/2022 | NMS Group | Private Equity Round | 0 |
8/2021 | Inceptio Technology | Series B | 0 |
1/2021 | Mobvista | Debt Financing | - |
12/2020 | Naixuecha | Series C | 0 |
11/2020 | Regional Express Holdings | Post-IPO Debt | 0 |
3/2020 | Akouos | Series B | 0 |
2/2020 | Yi Zizhu | Venture Round | 0 |
9/2019 | BioRay Pharmaceutical | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|